progression of DKD
pathogenesis of DKD
management of DKD
cure DKD
DKD Diabetic kidney disease
BEAt-DKD consortium
various stages of DKD
kidney model systems
biomarkers of disease progression
novel model systems
kidney disease-relevant IMI
appropriate model systems
systems biology
better biomarkers
kidney tissue
holistic systems medicine view
imaging techniques
prognostic biomarkers
leaders of diabetes
limited access
better understanding
leading cause of end stage renal disease
novel sub-classification of diabetes
acceptance of new tools
overall goals of BEAt
precision medicine
stagnating development of new treatments
relevant clinical cohorts
state-of-the-art analysis
nephropathy
trials
translational researchers
patients
accurate patient stratification
treatment responses
KIDNEYCONNECT
SUMMIT
steps
ESRD
pathways
epidemic dimensions
unprecedented search
long-standing experience
Aldosterone System
prevalence
Syskid
CPROBE
C-Path
FP7
targetable mechanisms
networks
likely reasons
initiation
aim
global incidence
US consortia
Biomarker Enterprise
blockade
RAAS
project
introduction
Renin-Angiotensin
recent years
effects
collaboration
regulatory agencies
Lack of predictive
effective means